chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site paraesthesia, Vaccination site swelling, Wheezing
Clinical narrative: Chills/rigors; wheezing; shortness of breath; cough; myalgias; local vaccination site swelling as well as tenderness and colorimetric changes (looked like a POPeye arm with yellow/green tingling hanging down in a large tear drop); local vaccination site swelling as well as tenderness and colorimetric changes (looked like a POPeye arm with yellow/green tingling hanging down in a large tear drop); local vaccination site swelling as well as tenderness and colorimetric changes (looked like a POPeye arm with yellow/green tingling hanging down in a large tear drop); local vaccination site swelling as well as tenderness and colorimetric changes (looked like a POPeye arm with yellow/green tingling hanging down in a large tear drop); This is a spontaneous report from a contactable physician (patient). A 66-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3283), via an unspecified route of administration on 20Jan2021 at a single dose on Right deltoid for COVID-19 immunization. Medical history included Chronic lymphocytic leukemia with 65% of cells lymph's, low WBC count (13500) otherwise; DM2, A1C usually close to 6.1; HTN. Unspecified concomitant medication taken. The patient previously took nickel and experienced allergies. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9331), intramuscular on 31Dec2020 12:15 PM at a single dose on left arm for COVID-19 immunization. The patient experienced chills, rigors, wheezing, shortness of breath, local vaccination site swelling as well as tenderness and colorimetric changes (looked like a POPeye arm with yellow/green tingling hanging down in a large tear drop), cough, myalgias on 20Jan2021 23:30. Therapeutic measures were taken as a result of the events which included Benadryl, Aleve, Nebulizer treatment, change in local temperature to help stop rigors. The outcome of the events was recovering. No other vaccine in four weeks. The patient was not pregnant. Not diagnosed with COVID prior vaccination. Not COVID tested post vaccination.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: severe joint pain; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient reported having severe joint pain and she was questioning if she should get the second dose of the vaccine. The second dose is scheduled for 28Jan2021. Outcome of the event was unknown.  Information on the lot/ batch number has been requested.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Headache
Clinical narrative: Headache; tiredness; nose bleeding; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248, expiration date was unknown), via an unspecified route of administration in the left arm on 20Jan2021 01:30 at a single dose for COVID-19 immunization. Medical history included chronic migraine from an unknown date and unknown if ongoing. Concomitant medication included citalopram and trazodone. The patient was not pregnant. The patient had no other vaccine in four weeks prior vaccination. She had no covid prior vaccination nor was she tested post vaccination. The patient experienced headache, tiredness, she had a nose bleed and added that most of the time, if she had a headache, her nose will bleed. The events occurred on an unspecified date in Jan2021 at 03:00 AM with outcome of recovered in Jan2021. No treatment received for the events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Minor sore arm at injection site; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration (left arm) on 20Jan2021 11:45 at single dose for Covid-19 immunization. The patient's medical history included "known allergies: phenothiazine drugs". There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received TDAP vaccine and experienced sore arm at injection site. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. On 21Jan2021, the patient experienced minor sore arm at injection site reported as "not nearly as bad as TDAP vaccine".  There was no treatment received for the adverse event. The outcome of event is recovering. The patient has not been tested for COVID-19 since the vaccination.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: mild diarrhea post shot; This is a spontaneous report from a contactable consumer (patient). A 21-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3302) via an unspecified route of administration on the left arm on 14Jan2021 13:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 20Jan2021 05:00 AM, the patient experienced mild diarrhea post shot. No treatment was received for the event. Event resulted to a doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the vaccine was administered was in a hospital in a Military Base. Post vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Headache, Pruritus, Rash pruritic
Clinical narrative: wrist got really itchy; I had rash on bicep over a week/I also broke out in a rash on my biceps of the same arm; slight rash and some kind of sprinkling; it is a slightly itchy; She also had a headache the night off and felt flushed; She also had a headache the night off and felt flushed; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took tamiflu for flu and had allergy. The patient said that the after getting the vaccine her wrist was inoculated and itchy. Her wrist got really itchy that was the only side effect from the vaccine for the first hour. The patient had rash on bicep over a week. She broke out in a rash on her biceps of the same arm. It was slight rash and some kind of sprinkling but it lasted for over a week and it was slightly itchy. She also had a headache the night off and felt flushed. She wanted to know if she can receive the second dose. The outcome of the event itchy rash was recovered on unspecified date and unknown for the other events.  Information on lot/batch number has been requested.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Site pain; joint pain in knees, back, and neck; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek9231), via an unspecified route of administration in the right arm on 20Jan2021 15:15 at a single dose for covid-19 immunization. Medical history included rheumatoid arthritis (RA) and Sjogren's syndrome; both from an unknown date. Concomitant medication included methotrexate, hydroxychloroquine, levothyroxine sodium (SYNTHROID), and folic acid. The patient previously took Codine and experienced allergy. The patient experienced site pain; and joint pain in knees, back, and neck on 21Jan2021 03:00. Outcome of the events was recovering. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events were assessed as non-serious. No treatment was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Heart rate, Heart rate increased
Clinical narrative: rapid heart beat; severe anxiety; This is a spontaneous report from a contactable healthcare professional (patient). A 44-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on the left arm on 20Jan2021 09:15 at single dose for COVID-19 immunization. Medical history included allergies: artificial orange in food and anxiety. Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC) for birth control. The patient previously took first dose of BNT162B2 for covid-19 immunization on an unspecified date; and ammonia and experienced allergies. The patient was not pregnant at the time of vaccination. On 20Jan2021 14:00, the patient experienced rapid heartbeat and severe anxiety. The patient didn't go to the hospital and just worked through it herself as she has anxiety anyway. This lasted for about 4 hours. The patient did not receive treatment for the events. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered on 20Jan2021.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Pain
Clinical narrative: muscle aches and pain; muscle aches and pain; dizziness; This is a spontaneous report from a contactable consumer (patient herself) via medical information team. A female patient of an unspecified age received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 20Jan2021, 10:30 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 20Jan2021 at 21:00, the patient experienced muscle aches and pain, and dizziness. The patient wanted to know if these were common side effects and if she can use TYLENOL after her first vaccination with the PFIZER-BIONTECH COVID-19 VACCINE. The patient has not recovered from the events.   Information on the lot/batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness, Fatigue, Feeling hot
Clinical narrative: sore throat; had chills; hot with a slight fever; hot with a slight fever; dizzy; tired/slept all day; congestion; severe headache; severe cough; achy/was in such pain all over; This is a spontaneous report from a contactable healthcare professional (patient). A 61-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249, expiration date unspecified), intramuscular on 18Jan2021 12:00 at single dose (left arm) for COVID-19 immunization. Medical history included slight hypertension and allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication included losartan. The patient took first dose of bnt162b2 on 28Dec2020, at 10:00 (lot EL1284) at left arm for COVID-19 immunization. When the patient went to bed that night about 10 hours after the shot, I was just achy on 18Jan2021, at 22:30. When she got up at 02:30, she was in such pain all over and had chills and was hot with a slight fever, was dizzy, and tired on 19Jan2021. When she woke up later and had to call off, she had all of that (worsening), plus congestion and severe headache on 19Jan2021. The patient slept all day, but developed a severe cough by that night and she took nighttime cold medication to sleep and when she woke up on Wednesday, she took the daytime ones. The patient reported that she still have achiness, was tired, and a sore throat and some cough on Thursday, 21Jan2021. The patient received therapy for the event severe cough; and patient did not received treatment for the rest of events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. Outcome of events was recovering.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: sore throat; had chills; hot with a slight fever; hot with a slight fever; dizzy; tired/slept all day; congestion; severe headache; severe cough; achy/was in such pain all over; This is a spontaneous report from a contactable healthcare professional (patient). A 61-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249, expiration date unspecified), intramuscular on 18Jan2021 12:00 at single dose (left arm) for COVID-19 immunization. Medical history included slight hypertension and allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication included losartan. The patient took first dose of bnt162b2 on 28Dec2020, at 10:00 (lot EL1284) at left arm for COVID-19 immunization. When the patient went to bed that night about 10 hours after the shot, I was just achy on 18Jan2021, at 22:30. When she got up at 02:30, she was in such pain all over and had chills and was hot with a slight fever, was dizzy, and tired on 19Jan2021. When she woke up later and had to call off, she had all of that (worsening), plus congestion and severe headache on 19Jan2021. The patient slept all day, but developed a severe cough by that night and she took nighttime cold medication to sleep and when she woke up on Wednesday, she took the daytime ones. The patient reported that she still have achiness, was tired, and a sore throat and some cough on Thursday, 21Jan2021. The patient received therapy for the event severe cough; and patient did not received treatment for the rest of events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. Outcome of events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable other health professional (HCP). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on 02Jan2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced shingles after receiving the first dose the following week (unspecified date) and was wondering if she should get the second dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: Bruise on the injection site/bruise around the area of the vaccine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3248; Expiration date was not reported) in Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, after the first dose of vaccination, the patient had bruise on the injection site/bruise around the area of the vaccine. The outcome of the event, bruise on the injection site/bruise around the area of the vaccine, was not recovered.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling of armpit lymph nodes; This is a spontaneous report from a contactable other health care professional. A 27-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL3247), via an unspecified route of administration from 18Jan2021 11:15 at SINGLE DOSE at left arm for covid-19 immunisation. Medical history included Prior to vaccination, the patient was diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any vaccine within 4 weeks prior to the vaccine.  There were no concomitant medications. On 18Jan2021 23:00, the patient experienced Swelling of armpit lymph nodes that started 12 ish hours later and is still here a full 60 hours later. It was unknown if the patient receive treatment for the event. The outcome of the event was not recovered.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: left supraclavicular lymphadenopathy; This is a spontaneous report from a contactable other health professional (patient). A 54-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: FK5730), via an unspecified route of administration (left arm) on 06Jan2021 03:30 at single dose for Covid-19 immunization. The patient has no medical history. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced left supraclavicular lymphadenopathy over a centimeter in diameter noticed it 10 days after injection on 16Jan2021 (16:00). There was no treatment received for the adverse event. The outcome of event was not recovered. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature abnormal, Disease recurrence, Fatigue, Lymphadenopathy, Neutrophil count
Clinical narrative: Swollen  cervical lymph node on right side with lump in throat; Swollen  cervical lymph node on right side with lump in throat; temperature; fatigue; fatigue; increased white count and nuetraphils; increased white count and nuetraphils; This is a spontaneous report from contactable nurse (patient).  A 38-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number requested), via an unspecified route of administration on 21Dec2020 at 16:00 on the right arm at a single dose for COVID-19 immunization. Medical history included fatigue and allergies to sulfa both from an unknown date and unknown if ongoing. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient's concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swollen cervical lymph node on right side with lump in throat, temperature and fatigue with increased white count and neutrophils (reported as nuetraphils) on 28Dec2020. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient was still being treated with antibiotics and had unspecified labs. The outcome of the events was not recovered. Since the vaccination, the patient had a nasal swab PCR test for COVID-19 on 02Jan2021 with a negative result.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil count increased, Pharyngeal mass, SARS-CoV-2 test, White blood cell count, White blood cell count increased
Clinical narrative: Swollen  cervical lymph node on right side with lump in throat; Swollen  cervical lymph node on right side with lump in throat; temperature; fatigue; fatigue; increased white count and nuetraphils; increased white count and nuetraphils; This is a spontaneous report from contactable nurse (patient).  A 38-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number requested), via an unspecified route of administration on 21Dec2020 at 16:00 on the right arm at a single dose for COVID-19 immunization. Medical history included fatigue and allergies to sulfa both from an unknown date and unknown if ongoing. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient's concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swollen cervical lymph node on right side with lump in throat, temperature and fatigue with increased white count and neutrophils (reported as nuetraphils) on 28Dec2020. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient was still being treated with antibiotics and had unspecified labs. The outcome of the events was not recovered. Since the vaccination, the patient had a nasal swab PCR test for COVID-19 on 02Jan2021 with a negative result.   Information on the lot/batch number has been requested.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Feeling abnormal, Headache, Vaccination site pain
Clinical narrative: Brain fog; anxiety; (minor) sudden brief sharp headache; soreness at injection site; This is a spontaneous report from a contactable consumer reporting for self.  A 81-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# EL9261,via an unspecified route of administration on 19Jan2021 15:30 (at the age of 81-years old), Dose 1, as a single dose, left arm  for COVID-19 immunization.  Medical history included high cholesterol and hypothyroidism.  The patient had not been diagnosed with COVID-19 prior to vaccination. Concomitant medication included levothyroxine, guaifenesin (ROBITUSSIN), and rosuvastatin calcium (CRESTOR).  The patient did not receive any other vaccinations in the 4 weeks prior to the COVID-19 vaccination. On 19Jan2021 at 15:45, the patient experienced brain fog and anxiety, which lasted approximately 20 minutes. Also (minor) sudden brief sharp headache and soreness at injection site. There was no hospitalization for the events. The patient received treatment for the events, reported as "Calming talk, deep breathing, rest." The events were reported as non-serious. The patient recovered from the events brain fog, anxiety on 19Jan2021 at 16:05 and recovered from sudden brief sharp headache and soreness at injection site on unspecified date(s). The patient had not been tested for COVID-19 since the immunization.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Lymphadenopathy, Nausea
Clinical narrative: weakness; chills; nausea; temp was 101.3/fever; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration on left arm on 18Jan2021 19:45 at a single dose for COVID-19 immunization. The patient had no medical history. The patient had no known allergies. The patient received other vaccines within 4 weeks prior to the COVID vaccine including Whooping cough vaccine (Pertussis vaccine) on 11Dec2020 (dose number 1, left arm). On 19Jan2021 19:30, the patient had weakness, chills, nausea and his temperature (temp) was 101.3. He came home Wednesday from work at the 44th hour and had all symptoms "accept" (as reported) for swollen lymph nodes. Patient's fever broke 6 hours later at 22:00 (as reported) Wednesday night (on 20Jan2021, also reported as 50 hours after the injection), he slept all night comfortably, woke up with no issues and temp was 96.1 (21Jan2021). At the time of the report the patient felt fine. There was no treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event fever was recovered on 20Jan2021 and other events recovered in Jan2021.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: weakness; chills; nausea; temp was 101.3/fever; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration on left arm on 18Jan2021 19:45 at a single dose for COVID-19 immunization. The patient had no medical history. The patient had no known allergies. The patient received other vaccines within 4 weeks prior to the COVID vaccine including Whooping cough vaccine (Pertussis vaccine) on 11Dec2020 (dose number 1, left arm). On 19Jan2021 19:30, the patient had weakness, chills, nausea and his temperature (temp) was 101.3. He came home Wednesday from work at the 44th hour and had all symptoms "accept" (as reported) for swollen lymph nodes. Patient's fever broke 6 hours later at 22:00 (as reported) Wednesday night (on 20Jan2021, also reported as 50 hours after the injection), he slept all night comfortably, woke up with no issues and temp was 96.1 (21Jan2021). At the time of the report the patient felt fine. There was no treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event fever was recovered on 20Jan2021 and other events recovered in Jan2021.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Fatigue, Headache, Muscular weakness
Clinical narrative: headache; tiredness; get palpitations; chest pain; arm weakness when standing too long; Anxiety; This is a spontaneous report from a contactable other HCP (patient). A 45-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number reported as 5730, pending clarification), via an unspecified route of administration on 18Dec2020 at single dose in left arm for COVID-19 immunisation. Patient age at vaccination was 45 years. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included asthma and known allergies to epinephrine, latex, sulfa. Concomitant medications included amoxicillin (AMOXICILLIN), ibuprofen (MOTRIN). On 19Dec2020 at 01:00 PM the patient had headache and tiredness ever since get palpitations, chest pain, arm weakness when standing too long or when first get up. Heart doctor thinks it's due to vaccine or anxiety but never had this before shot. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment for the events included anti anxiety medication, metoprolol. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination the patient was tested for COVID-19 (nasal swab) on 18Jan2021 which resulted negative.  Information about lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, SARS-CoV-2 test
Clinical narrative: headache; tiredness; get palpitations; chest pain; arm weakness when standing too long; Anxiety; This is a spontaneous report from a contactable other HCP (patient). A 45-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number reported as 5730, pending clarification), via an unspecified route of administration on 18Dec2020 at single dose in left arm for COVID-19 immunisation. Patient age at vaccination was 45 years. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included asthma and known allergies to epinephrine, latex, sulfa. Concomitant medications included amoxicillin (AMOXICILLIN), ibuprofen (MOTRIN). On 19Dec2020 at 01:00 PM the patient had headache and tiredness ever since get palpitations, chest pain, arm weakness when standing too long or when first get up. Heart doctor thinks it's due to vaccine or anxiety but never had this before shot. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment for the events included anti anxiety medication, metoprolol. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination the patient was tested for COVID-19 (nasal swab) on 18Jan2021 which resulted negative.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dysgeusia, Hyperhidrosis
Clinical narrative: metal taste in her mouth; She also felt like she was burning up inside; She was sweating and her body felt extremely warm inside; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the COVID vaccine morning on 21Jan2021, and 15 to 30 minutes later, she had a metal taste in her mouth and was still having the metal taste in her mouth. She also felt like she was burning up inside out. She was sweating and her body felt extremely warm inside. Events were reported as non-serious. Outcome of the event metal taste in her mouth was not recovered, while unknown for the other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nasal discomfort, Pain in extremity, Rhinorrhoea, Vaccination site pain
Clinical narrative: Some irritation in my nose/on the inside of his left nostril; Runny nose; Little pain in the arm; Some minor pain at the COVID-19 Vaccine injection site; Headache; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 20Jan2021 (09:00) at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 20Jan2021, in the evening, the patient had a little pain in the arm; some minor pain at the COVID-19 vaccine injection site; and headache. The patient had received paracetamol (TYLENOL) as treatment for the headache. On 21Jan2021, the patient had some irritation in the nose/on the inside of his left nostril; and runny nose. The outcome of the events, 'little pain in the arm', 'minor pain at the vaccine injection site', 'headache', 'some irritation in the nose/inside of left nostril' and 'runny nose', was unknown.  Information about lot/batch number is requested.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Feeling abnormal, Frustration tolerance decreased, Headache, Malaise
Clinical narrative: not feeling well/general malaise/feeling sick; feeling really bad; a bad headache; feeling sick and nauseated/nausea; worried it will not go away; frustrated; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI283, expiry date unknown), via an unspecified route of administration in the right arm, on 11Jan2021, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported she had her first vaccine on 11Jan2021. On 19Jan2021, the patient was feeling really bad, had a bad headache, general malaise and was feeling sick and nauseated. She was not feeling well and has not been feeling well the last 3 days. She thought the side effect would be right after getting the vaccine however hers started on 19Jan2021 (2 days ago). She stated she had an awful headache which she still has and had nausea. She wanted to know if it was normal to have happened this far away from receiving the vaccine, this amount of time from the vaccine. The patient reported that she is not quite as bad now, but she still feels it. The patient was worried it will not go away (Jan2021). The patient became frustrated and stated that she was just trying to find out if what she was feeling was normal. The patient also thought she had COVID and took a test in Jan2021 but she did not have COVID (negative). The outcome of the events "not feeling well/general malaise/feeling sick", "feeling really bad", "a bad headache" and "feeling sick and nauseated/nausea" was recovering; and the outcome of "worried it will not go away" and "frustrated" was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test
Clinical narrative: not feeling well/general malaise/feeling sick; feeling really bad; a bad headache; feeling sick and nauseated/nausea; worried it will not go away; frustrated; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI283, expiry date unknown), via an unspecified route of administration in the right arm, on 11Jan2021, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported she had her first vaccine on 11Jan2021. On 19Jan2021, the patient was feeling really bad, had a bad headache, general malaise and was feeling sick and nauseated. She was not feeling well and has not been feeling well the last 3 days. She thought the side effect would be right after getting the vaccine however hers started on 19Jan2021 (2 days ago). She stated she had an awful headache which she still has and had nausea. She wanted to know if it was normal to have happened this far away from receiving the vaccine, this amount of time from the vaccine. The patient reported that she is not quite as bad now, but she still feels it. The patient was worried it will not go away (Jan2021). The patient became frustrated and stated that she was just trying to find out if what she was feeling was normal. The patient also thought she had COVID and took a test in Jan2021 but she did not have COVID (negative). The outcome of the events "not feeling well/general malaise/feeling sick", "feeling really bad", "a bad headache" and "feeling sick and nauseated/nausea" was recovering; and the outcome of "worried it will not go away" and "frustrated" was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: first injection of the Pfizer BioNTech COVID-19 vaccine 2 weeks ago and the only side effect she experienced was some mild pain at the site of injection; I was told we had no side effects at all thank goodness just the sore arm; This is a spontaneous report from a contactable consumer.  A 70-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously had a flu and shingles shot. The patient asked the side effects after the second shot compared to the first in older people. She wanted to known if they need to be monitored more after the second shot. The consumer reported receiving her first injection of the Pfizer BioNTech COVID-19 vaccine 2 weeks ago and the only side effect she experienced was some mild pain at the site of injection that lasted only a day. The consumer reports the pain was similar to what she experienced in the past after a flu shot and a shingles shot. The consumer reported when she was told by people where she received her injection that people react more to the second shot compared to the first, and younger people react more to the injections that older people for side effects like headache and fever. The consumer also stated, "Here is the question, my mother who is going to be 97 and I, who is going to be 70 received the first Pfizer Shot a couple (Covid-19 Vaccine) of weeks ago, we are due for the second shot for next Thursday actually and I was told we had no side effects at all thank goodness just the sore arm. Now I was told for the second shot that you usually do get some kind of side effects, so my question is my mother and I taking a shot at the same time, I live along with her and should I have somebody with me just what are the odds we are going to have side effects from the second shot, I guess that's my question." The outcome of the event mild pain at the site of injection was recovered while other event was unknown.  Information on the Lot/Batch Number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eye pain, Headache, Hyperhidrosis, Lymphadenopathy
Clinical narrative: bad headache that felt like migraine; bad headache that felt like migraine; thought it might be a sinus headache; pain on the right side of the back of her neck that radiated behind her right eye; pain on the right side of the back of her neck that radiated behind her right eye; dizziness; sweating; swollen lymph nodes in her throat; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 15Jan2021 at 07:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 15Jan2021, the patient experienced dizziness, sweating, and swollen lymph nodes in her throat. On 18Jan2021, the patient started to get a really bad headache that felt like migraine and thought it might be a sinus headache. On the same day, the patient also had pain on the right side of the back of her neck that radiated behind her right eye. The patient would like to know if she could take anything for her headache. The outcome of the event bad headache that felt like migraine was not recovered while the other events was unknown.  Information about lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Neck pain, Sinus headache
Clinical narrative: bad headache that felt like migraine; bad headache that felt like migraine; thought it might be a sinus headache; pain on the right side of the back of her neck that radiated behind her right eye; pain on the right side of the back of her neck that radiated behind her right eye; dizziness; sweating; swollen lymph nodes in her throat; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 15Jan2021 at 07:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 15Jan2021, the patient experienced dizziness, sweating, and swollen lymph nodes in her throat. On 18Jan2021, the patient started to get a really bad headache that felt like migraine and thought it might be a sinus headache. On the same day, the patient also had pain on the right side of the back of her neck that radiated behind her right eye. The patient would like to know if she could take anything for her headache. The outcome of the event bad headache that felt like migraine was not recovered while the other events was unknown.  Information about lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Blood pressure measurement
Clinical narrative: Blood pressure keeps going up and down for couple hours; This is a spontaneous report from a contactable nurse (patient herself). A 49-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) via an unspecified route of administration in the right arm, on 18Jan2021 at 13:15, at a single dose, for COVID-19 immunization. Relevant medical history included blood pressure abnormal. Concomitant medications included spironolactone. The patient previously received amoxicillin and experienced allergies. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the Nursing Home/Senior Living Facility. On 18Jan2021, at 13:15, the patient's blood pressure keeps going up and down for couple hours. The patient did not receive treatment for the event. Outcome of the event was recovered with sequel. The patient has not been tested for COVID-19 since vaccination.  Information on batch/lot number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: fever; chills; nausea; headache; myalgias; This is a spontaneous report from a non-contactable healthcare professional. A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. There were no other vaccine received within 4 weeks prior to COVID vaccination. The patient experienced fever, chills, nausea, headache and myalgias. No treatment was received. Outcome of the events was unknown. The event was reported non-serious. It was unknown if patient was diagnosed with COVID-19 prior to vaccination and has not been tested since the vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Lymphadenopathy, Paraesthesia, Vaccination site lymphadenopathy
Clinical narrative: Experienced dizziness the first week after vaccination; Axillary lymph node swelling to arm of injection; Axillary lymph node swelling to arm of injection; hands and feet tingling/numbness/Feels as if hands and feet are falling asleep often; hands and feet tingling/numbness/Feels as if hands and feet are falling asleep often; This is a spontaneous report received from a contactable nurse (who is also the patient). A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 30Dec2020 14:00, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 06Jan2021 at 14:00, first week after the vaccination, the patient experienced dizziness, axillary lymph node swelling to arm of injection 1 week until now after vaccination, and hands and feet tingling/numbness at random times of the day and feels as if hands and feet are falling asleep often. The events resulted to "doctor or other healthcare professional office/clinic visit". No treatment for the events was given. The outcome of the events was not recovered. The events were assessed as non-serious.  Information on the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Left arm has red itchy mark about the size of a silver dollar where shot was; Left arm has red itchy mark about the size of a silver dollar where shot was; This is a spontaneous report from a contactable consumer, the patient. This 34-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EL0142), dose number 1, via an unspecified route of administration in the left arm on 07Jan2021 at 11:30 (at the age of 34-years-old) as a single dose for COVID-19 vaccination. Medical history included asthma from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, sulfa allergy from an unknown date and unknown if ongoing and penicillin allergy from an unknown date and unknown if ongoing. Concomitant medication included sertraline hydrochloride (ZOLOFT), unspecified birth control and salbutamol sulfate (ALBUTEROL [SALBUTAMOL SULFATE]). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 21Jan2021 at 10:00, the patient experienced her left arm has a red, itchy mark about the size of a silver dollar where the shot was. No therapeutic measures were taken as a result of the events. The clinical outcomes of her left arm has a red, itchy mark about the size of a silver dollar where the shot was not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: She has a fever of 100.2F and loss of appetite/No appetite; She has a fever of 100.2F and loss of appetite.; Feeling unwell; Injection site pain; Tiredness; Headache; Chills; This is a spontaneous report from a contactable nurse reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 20Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient and her husband received the COVID vaccine yesterday early in the morning at a hospital. She was fine until the middle of the night and early this morning. On Jan2021, she had 6 of the 12 side effects, which she described as injection site pain, tiredness, headache, chills, feeling unwell and no appetite. She had a headache and felt her forehead and it felt warm, so she took her temperature and it was 100.2 degrees Fahrenheit. She has a fever of 100.2F. The patient underwent lab tests and procedures which included body temperature: 100.2 on Jan2021. The outcome of the events was unknown.   Information on the Batch/Lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia, Vaccination site pain
Clinical narrative: She has a fever of 100.2F and loss of appetite/No appetite; She has a fever of 100.2F and loss of appetite.; Feeling unwell; Injection site pain; Tiredness; Headache; Chills; This is a spontaneous report from a contactable nurse reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 20Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient and her husband received the COVID vaccine yesterday early in the morning at a hospital. She was fine until the middle of the night and early this morning. On Jan2021, she had 6 of the 12 side effects, which she described as injection site pain, tiredness, headache, chills, feeling unwell and no appetite. She had a headache and felt her forehead and it felt warm, so she took her temperature and it was 100.2 degrees Fahrenheit. She has a fever of 100.2F. The patient underwent lab tests and procedures which included body temperature: 100.2 on Jan2021. The outcome of the events was unknown.   Information on the Batch/Lot number has been requested.